HF
CUE icon

HRT Financial’s Cue Biopharma CUE Stock Holding History

HRT Financial’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-695
Closed -$6K – 3944
2025
Q4 		$6K Buy
+695
New +$12.8K ﹤0.01% 3061
2025
Q3 		– Sell
-394
Closed -$8K – 2989
2025
Q2 		$8K Buy
+394
New +$8.41K ﹤0.01% 2465
2025
Q1 		– Sell
-1,635
Closed -$53K – 2652
2024
Q4 		$53K Buy
+1,635
New +$61.4K ﹤0.01% 2100
2024
Q3 		– Sell
-1,761
Closed -$65K – 2542
2024
Q2 		$65K Buy
+1,761
New +$87.1K ﹤0.01% 1808
2022
Q2 		– Sell
-3,496
Closed -$511K – 3053
2022
Q1 		$511K Buy
+3,496
New +$741K ﹤0.01% 1621
2021
Q4 		– Sell
-906
Closed -$396K – 3327
2021
Q3 		$396K Buy
+906
New +$316K ﹤0.01% 2217

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

HRT Financial's CUE Position: Q1 2026 in Review

HRT Financial sold out of Cue Biopharma (CUE) in Q1 2026, closing a stake of 695 shares — an estimated $6K sold.

HRT Financial first reported a position in CUE in Q3 2021 and held it in 6 quarters. The position peaked at $511K in Q1 2022. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • HRT Financial reported no remaining Cue Biopharma position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 695 Cue Biopharma shares in Q1 2026, an estimated $6K.
  • HRT Financial first reported a position in Cue Biopharma in Q3 2021 and held it in 6 quarters.
  • HRT Financial's Cue Biopharma position peaked at $511K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.